Novadip

Novadip is a late-stage clinical biotechnology company specializing in regenerative medicine. From its funding announcement.

€10M ConvertibleRaised 3 days agoMont Saint-Guibert, BelgiumBiotech & PharmaBelgium
Visit website →

In their own words

What Novadip says it is doing

Work here? Claim your company profile

Public signal Described in the funding announcement as "late-stage clinical biotechnology company specializing in regenerative medicine". Source

Research and developmentRegulatory

Public signal Read from the company's own description of what the funding supports.

Why now

Where Novadip is today

Novadip announced a funding round of €10M on 21 September 2026, led by New Science Ventures.

Latest round
Convertible
Amount
€10M
Announced
21 September 2026
Headquarters
Mont Saint-Guibert, Belgium
Sector
Biotech & Pharma
Growth stage
Growth
Investors
Also participating
Fund+, Wallonie Entreprendre, VIVES Fund, ORSA Tech, Sambrinvest, Noshaq, Invest.BW
Relevant leadership
Not stated

Momentum AfterRaise intelligence

AfterRaise Score

60
Steady growth
1 funding signal in the last 90 days
Funding recency
40/40
announced within the last 30 days
Round scale
12/25
round size relative to the market
Funding stage
8/20
Convertible
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Since the raise

What has happened since

  • 21 September 2026
    €10M Convertible
    Led by New Science Ventures.

Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

What may happen next

What this raise could create

AfterRaise intelligenceNot a statement of fact

What may happen next

  • Research programme expansion
  • Scientific team growth
  • Regulatory and certification milestones
  • Compliance team growth

Opportunities this could create

  • Clinical operations
  • Regulatory affairs
  • Quality systems
  • Scientific hiring
  • Scientific advisers

Based on the Biotech & Pharma sector, a Growth round and the priorities the company itself set out. Not a statement of fact.

Medium momentum3 connected signals
  • 21 September 2026€10M Convertible announced
  • 21 September 2026Stated priority: research and development
  • 21 September 2026Stated priority: regulatory

High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.

Open to

What Novadip is open to

Not yet specified

Novadip has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Opportunities

Ways to work with Novadip

No open opportunities listed

Jobs, projects, partnerships, advisory and supplier needs appear here once the company has claimed its page and published them, and any role we read from its own job board appears automatically.

Work here? Open the first one

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Do you work at Novadip?

Claim your company profile.

This page was created from publicly available information. A verified representative corrects the record, says what the company is building next and chooses which conversations it welcomes.

What we do not have yet: the roles and projects you have open and who leads the team. Claiming the page is how you fill those in.

Someone else requesting access does not give them ownership. Every representative is verified by a person before access is granted.

Maintaining your own company profile is free. A founder, CEO or authorised senior colleague can represent the company.

Also moving

Other Biotech & Pharma companies

See the sector